Valeant Pharmaceuticals International Inc (NYSE:VRX)

17.18
Delayed Data
As of Apr 20
 -0.15 / -0.87%
Today’s Change
8.31
Today|||52-Week Range
24.43
-17.32%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Paulson & Co Inc
Director
Sale3/06/20187,066,629$15.40$108.8M+12.14%
Paulson & Co Inc
Director
Buy3/06/20187,066,629$15.40$108.8M+12.14%
Paulson & Co Inc
Director
Buy11/16/2017344,216$14.40$5.0M+19.80%
Paulson & Co Inc
Director
Sale11/16/2017344,216$14.39$5.0M+19.80%
Papa Joseph C
Chairman & Chief Executive Officer
Buy3/13/201830,000$16.05$481.5K+6.84%
Humphries William D
Chairman
Sale1/03/201814,730$20.78$306.1K-25.34%
De Schutter Richard U
Director
Buy5/11/201720,000$13.90$278.0K+24.49%
Herendeen Paul S
Chief Financial Officer & Executive Vice President
Sale8/23/201717,175$14.14$242.9K+19.14%
Herendeen Paul S
Chief Financial Officer & Executive Vice President
Buy3/13/201815,000$16.10$241.5K+6.84%
De Schutter Richard U
Director
Buy3/08/201810,000$15.34$153.4K+12.51%
Page of 6